{"nct_id":"NCT04260009","title":"Pharmacokinetics, Safety, and Efficacy of Brigatinib Monotherapy in Pediatric and Young Adult Participants With ALK+ Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors or Other Solid Tumors","status":"WITHDRAWN","status_verified_date":"2020-03","start_date":"2020-09-01","start_date_type":"ESTIMATED","primary_completion_date":"2023-09-01","primary_completion_date_type":"ESTIMATED","completion_date":"2025-09-01","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["TAK"]}